-
Founded in:
2003-09-28 -
Country:
China -
Address:
Chongka, Jiangna Town, Yanshan County, Wenshan Zhuang and Miao Autonomous Prefecture, Yunnan Province -
Tax NO.:
9153000077048614XN -
Registered Funds:
- -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Panax notoginsenosides |
1. It has anti-cerebral ischemia effect, improves brain edema in rats with multiple cerebral infarctions, promotes glial cell reaction, reduces hippocampal neuronal lesions, protects delayed hippocampal neuronal damage after transient cerebral ischemia in gerbils, reduces the Ca2 content in brain tissue after ischemia, reduces the number of dead neurons, and increases neuronal density; 2. It has anti-myocardial ischemia effect, reduces the symptoms of acute myocardial ischemia in rats induced by isoproterenol, and adjusts the ST-T segment recovery and electrocardiographic inhomogeneity of patients with angina pectoris due to coronary heart disease; 3. It improves blood rheology, reduces whole blood viscosity, plasma viscosity, hematocrit, platelet aggregation rate, slows down erythrocyte sedimentation rate, and reduces fibrinogen content; 4. It improves microcirculation, reduces nail fold microcirculation integral in patients with cerebral infarction and essential hypertension, reduces peri-loop exudation, increases flow rate, reduces red blood cell aggregation and congestion, improves loop clarity, and subsides edema; 5. It has the effect of lowering blood lipids, reducing total cholesterol and triglycerides in patients with type 2 diabetes, and reducing serum triglycerides, cholesterol and low-density lipoprotein levels in patients with angina pectoris and cerebral infarction due to coronary heart disease; 6. It has the effect of resisting free radical damage, increasing the activity of superoxide dismutase in erythrocytes of patients with coronary heart disease, reducing plasma malondialdehyde levels, and reducing serum protein kinase C and aspartate aminotransferase levels.
More
1. It has anti-cerebral ischemia effect, improves brain edema in rats with multiple cerebral infarctions, promotes glial cell reaction, reduces hippocampal neuronal lesions, protects delayed hippocampal neuronal damage after transient cerebral ischemia in gerbils, reduces the Ca2 content in brain tissue after ischemia, reduces the number of dead neurons, and increases neuronal density; 2. It has anti-myocardial ischemia effect, reduces the symptoms of acute myocardial ischemia in rats induced by isoproterenol, and adjusts the ST-T segment recovery and electrocardiographic inhomogeneity of patients with angina pectoris due to coronary heart disease; 3. It improves blood rheology, reduces whole blood viscosity, plasma viscosity, hematocrit, platelet aggregation rate, slows down erythrocyte sedimentation rate, and reduces fibrinogen content; 4. It improves microcirculation, reduces nail fold microcirculation integral in patients with cerebral infarction and essential hypertension, reduces peri-loop exudation, increases flow rate, reduces red blood cell aggregation and congestion, improves loop clarity, and subsides edema; 5. It has the effect of lowering blood lipids, reducing total cholesterol and triglycerides in patients with type 2 diabetes, and reducing serum triglycerides, cholesterol and low-density lipoprotein levels in patients with angina pectoris and cerebral infarction due to coronary heart disease; 6. It has the effect of resisting free radical damage, increasing the activity of superoxide dismutase in erythrocytes of patients with coronary heart disease, reducing plasma malondialdehyde levels, and reducing serum protein kinase C and aspartate aminotransferase levels. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| NOTOGINSENG RADIX ET RHIZOMA |
|
0 | ||
| Ginseng essence |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Three seven roots |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Salvia Root P.E Tanshinone IIA 20% |
Dilate coronary arteries, increase coronary blood flow, improve myocardial hypoxia; improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in electrocardiograms; inhibit platelet aggregation, reduce blood viscosity, and lower blood lipids
More
Dilate coronary arteries, increase coronary blood flow, improve myocardial hypoxia; improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in electrocardiograms; inhibit platelet aggregation, reduce blood viscosity, and lower blood lipids |
0 | ||
| NOTOGINSENG RADIX ET RHIZOMA |
Dilate coronary arteries, increase coronary blood flow, improve myocardial hypoxia; improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in electrocardiograms; inhibit platelet aggregation, reduce blood viscosity, and lower blood lipids
More
Dilate coronary arteries, increase coronary blood flow, improve myocardial hypoxia; improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in electrocardiograms; inhibit platelet aggregation, reduce blood viscosity, and lower blood lipids |
0 | ||
| Borneol |
Dilate coronary arteries, increase coronary blood flow, improve myocardial hypoxia; improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in electrocardiograms; inhibit platelet aggregation, reduce blood viscosity, and lower blood lipids
More
Dilate coronary arteries, increase coronary blood flow, improve myocardial hypoxia; improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in electrocardiograms; inhibit platelet aggregation, reduce blood viscosity, and lower blood lipids |
507-70-0 | 1 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| NOTOGINSENG RADIX ET RHIZOMA |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
0 |